Founded in 2004, Esperante Ventures invests between €300,000 to €700,000 for an equity stake of 3% to 33% in startups that are 6-10 years old. They have a preference for startups with fewer founders and typically invest in rounds with 3-4 participants. Some of their notable investments include Versantis, Arquer Diagnostics, and Oxford Cancer Biomarkers. Esperante Ventures is controlled by C&P Group Holdings, a privately controlled life sciences interest group, and aims to achieve financial independence or a liquidity event within five years for their portfolio companies.